ESSENDANT INC (ESND) Stock Fundamental Analysis

NASDAQ:ESND - Nasdaq - US2966891028

12.8 +0.01 (+0.08%)

After market: 12.81 +0.01 (+0.08%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

No Fundamental Analysis report for ESND not available.

NASDAQ:ESND (1/30/2019, 8:00:00 PM)

After market: 12.81 +0.01 (+0.08%)

12.8

+0.01 (+0.08%)

Chartmill FA Rating

GICS SectorN/A

GICS IndustryGroupN/A

GICS IndustryN/A

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners81.96%

Inst Owner Change0%

Ins Owners1.21%

Ins Owner Change0%

Market Cap481.82M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	4.38%

Yearly Dividend0.56

Dividend Growth(5Y)1.13%

DP-36.23%

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	1280
Fwd PE	11.33
P/S	0.1
P/FCF	N/A
P/OCF	N/A
P/B	1.11
P/tB	N/A
EV/EBITDA	154.94

EPS(TTM)0.01

EY0.08%

EPS(NY)1.13

Fwd EY8.83%

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS132.49

BVpS11.51

TBVpSN/A

PEG (NY)18.64

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-3.21%
ROE	-13.29%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	-0.75%
PM (TTM)	-1.15%
GM	N/A
FCFM	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3Y0%

ROICexcg growth 5Y0%

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover2.78

Health

		Industry Rank	Sector Rank
Debt/Equity	1.18
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.96
Quick Ratio	0.98
Altman-Z	4.2

F-Score4

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-56.49%

EPS 3YN/A

EPS 5Y-68.63%

EPS Q2Q%-566.67%

EPS Next Y68.66%

EPS Next 2Y-19.17%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-2.09%

Revenue growth 3YN/A

Revenue growth 5Y-0.39%

Sales Q2Q%-1.1%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1YN/A

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1YN/A

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1YN/A

OCF growth 3YN/A

OCF growth 5YN/A